-
1.发明申请公开(公告)号：US20140213570A1
公开(公告)日：2014-07-31
申请号：US14242282
申请日：2014-04-01
申请人： Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
发明人： Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
IPC分类号： C07D401/14 , A61K31/5377 , C07D487/04 , A61K31/501 , C07D401/12 , C07D471/10 , C07D471/04 , C07D413/14 , C07D417/14 , C07D403/12 , C07D403/14 , C07D487/10 , A61K31/551 , C07D409/14
CPC分类号： A61K31/501 , A61K31/41 , A61K31/427 , A61K31/502 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K45/06 , C07D237/06 , C07D237/20 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/08 , C07D471/10 , C07D487/04 , C07D487/10
摘要： The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
-
2.发明申请1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS 有权用于治疗SMN缺陷相关病症的1,4-取代吡嗪类化合物及其方法公开(公告)号：US20140051672A1
公开(公告)日：2014-02-20
申请号：US13960917
申请日：2013-08-07
申请人： Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy Brian HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
发明人： Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy Brian HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
IPC分类号： C07D401/12 , A61K45/06 , C07D409/14 , C07D401/14 , A61K31/502 , C07D413/14 , C07D417/14 , A61K31/5377 , C07D403/12 , A61K31/551 , C07D471/08 , C07D471/10 , C07D471/04 , C07D403/14 , C07D403/10 , C07D487/10 , C07D487/04 , C07D237/20 , C07D401/04 , C07D405/14 , A61K31/506 , A61K31/501
CPC分类号： A61K31/501 , A61K31/41 , A61K31/427 , A61K31/502 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K45/06 , C07D237/06 , C07D237/20 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/08 , C07D471/10 , C07D487/04 , C07D487/10
摘要： The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译： 本发明提供式I化合物或其药学上可接受的盐; 制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
3.发明申请THIADIAZOLE ANALOGS THEREOF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED-CONDITIONS 审中-公开其类似物及其治疗微不足道相关疾病的方法公开(公告)号：US20150218175A1
公开(公告)日：2015-08-06
申请号：US14688447
申请日：2015-04-16
申请人： Jake AXFORD , Natalie DALES , Moo Je SUNG
发明人： Jake AXFORD , Natalie DALES , Moo Je SUNG
IPC分类号： C07D487/04 , A61K31/454 , C07D417/12 , A61K31/4709 , A61K31/4545 , A61K31/433 , C07D417/10 , A61K31/496 , C07D471/04 , A61K31/437 , A61K31/506 , A61K31/5377 , C07D471/10 , A61K31/4353 , C07D417/14
CPC分类号： C07D487/04 , A61K31/433 , A61K31/435 , A61K31/4353 , A61K31/437 , A61K31/438 , A61K31/4436 , A61K31/454 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D417/10 , C07D417/12 , C07D417/14 , C07D471/04 , C07D471/10 , C07D487/10 , C07D487/20
摘要： The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译： 本发明提供式（X）的化合物或其药学上可接受的盐; 制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
4.发明申请THIADIAZOLE ANALOGS THEREOF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED-CONDITIONS 有权其类似物及其治疗微不足道相关疾病的方法公开(公告)号：US20140206661A1
公开(公告)日：2014-07-24
申请号：US14160180
申请日：2014-01-21
申请人： Jake AXFORD , Natalie DALES , Moo Je SUNG
发明人： Jake AXFORD , Natalie DALES , Moo Je SUNG
IPC分类号： C07D417/14 , C07D417/12 , A61K31/4709 , C07D487/04 , A61K31/433 , A61K45/06 , A61K31/437 , A61K31/506 , A61K31/5377 , C07D471/10 , A61K31/435 , A61K31/454 , C07D471/04
CPC分类号： C07D487/04 , A61K31/433 , A61K31/435 , A61K31/4353 , A61K31/437 , A61K31/438 , A61K31/4436 , A61K31/454 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D417/10 , C07D417/12 , C07D417/14 , C07D471/04 , C07D471/10 , C07D487/10 , C07D487/20
摘要： The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译： 本发明提供式（X）的化合物或其药学上可接受的盐; 制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
5.发明申请1,4-DISUBSTITUTED PYRIDAZINE QUINOLNE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS 审中-公开用于治疗SMN缺陷相关病症的1,4-取代吡啶并喹啉类似物及其方法公开(公告)号：US20160184305A1
公开(公告)日：2016-06-30
申请号：US14909052
申请日：2014-07-30
IPC分类号： A61K31/501 , C07D487/04 , C07D413/14 , C07D405/14 , A61K31/517 , C07D401/04 , C07D401/14 , A61K31/5377
CPC分类号： A61K31/501 , A61K31/517 , A61K31/5377 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14 , C07D487/04
摘要： The present invention provides a compound of formula IA or a pharmaceutically acceptable salt thereof; 5 (IA) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译： 本发明提供式IA化合物或其药学上可接受的盐; 5（IA）制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
-
-
-
搜索结果
5 条记录 (耗时 0.052 秒)
